Walleye Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-33,730
Closed -$2.42M 3651
2022
Q2
$2.42M Sell
33,730
-1,308
-4% -$95.6K 0.07% 311
2022
Q1
$2.84M Buy
35,038
+15,161
+76% +$1.28M 0.08% 270
2021
Q4
$2.04M Buy
+19,877
New +$1.91M 0.06% 323

Other funds holding SYNH

Walleye Capital's SYNH Position: Q3 2022 in Review

Walleye Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 33,730 shares — an estimated $2.42M sold.

Walleye Capital first reported a position in SYNH in Q4 2021 and held it in 3 quarters. The position peaked at $2.84M in Q1 2022. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • Walleye Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Walleye Capital sold 33,730 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $2.42M.
  • Walleye Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • Walleye Capital's Syneos Health, Inc. Class A Common Stock position peaked at $2.84M in Q1 2022.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.